Godwin, C D
Gale, R P
Walter, R B
Article History
Received: 13 April 2017
Revised: 26 May 2017
Accepted: 31 May 2017
First Online: 13 June 2017
Competing interests
: RPG is a part-time employee of Celgene Corp. RBW has received laboratory research grants and/or clinical trial support from ADC Therapeutics, Inc., Amgen Inc., Amphivena Therapeutics, Inc., Aptevo Therapeutics, Inc., Covagen AG, Seattle Genetics, Inc. and Stemline Therapeutics, Inc. has ownership interests with Amphivena Therapeutics, Inc. and is (or has been) a consultant to Amphivena Therapeutics, Inc., Covagen AG, Emergent Biosolutions, Inc. (now Aptevo Therapeutics, Inc.), Pfizer, Inc., Seattle Genetics, Inc. and Jazz Pharmaceuticals, Inc.